(Q36814278)

16 August 2017

1 reference

title

Centrally acting antihypertensive agents: an update (English)

1 reference

16 August 2017

Domenic A Sica

1

1 reference

16 August 2017

1 May 2007

1 reference

Journal of Clinical Hypertension

16 August 2017

1 reference

16 August 2017

9

1 reference

16 August 2017

5

1 reference

16 August 2017

399-405

1 reference

Department of veterans Affairs single-drug therapy of hypertension study. Revised figures and new data. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents

16 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.07161.X

Methyldopa. Mechanisms and treatment 25 years later

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.07161.X

Moxonidine: a review of its use in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.07161.X

Rilmenidine: a clinical overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.07161.X

Effect of Methyldopa on Plasma Renin Activity in Man

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.07161.X

Oral clonidine in patients with asthma: no significant effect on airway reactivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.07161.X

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.07161.X

Effects of antihypertensive drugs on the unborn child: what is known, and how should this influence prescribing?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.07161.X

Treatment of hypertensive emergencies and urgencies with oral clonidine loading and titration. A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.07161.X

Use of centrally acting sympatholytic agents in the management of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.07161.X

Adverse mortality effect of central sympathetic inhibition with sustained‐release moxonidine in patients with heart failure (MOXCON)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.07161.X

Clinical assessment of clonidine in the treatment of new-onset rapid atrial fibrillation: a prospective, randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.07161.X

Risk factors for severe bradycardia during oral clonidine therapy for hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.07161.X

Blood pressure crisis following withdrawal of clonidine (Catapres, Catapresan), with special reference to arterial and urinary catecholamine levels, and suggestions for acute management

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.07161.X

Relationship between plasma concentrations of clonidine and mean arterial pressure during an accidental clonidine overdose

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.07161.X

Skin pretreatment and the use of transdermal clonidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.07161.X

10.1111/J.1524-6175.2007.07161.X

21 January 2018

Identifiers

DOI

1 reference

16 August 2017

1 reference

PubMed ID

17485976